INKON Life Technology Co., Ltd. (SHE:300143)

Market Cap	7.93B
Revenue (ttm)	1.69B
Net Income (ttm)	119.72M
Shares Out	743.29M
EPS (ttm)	0.17
PE Ratio	64.35
Forward PE	57.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,382,662
Average Volume	6,850,168
Open	10.54
Previous Close	10.67
Day's Range	10.40 - 10.64
52-Week Range	8.12 - 13.13
Beta	0.67
RSI	39.74
Earnings Date	Oct 28, 2025

About INKON Life Technology

INKON Life Technology Co., Ltd. focuses on building an ecological platform for chain of pre-diagnosis/treatment/health providing medical services for tumors in China and internationally. The company engages in the research, development, innovation, and services of scenarios and equipment medical devices. The company was formerly known as Starmap Medicine and Technology Co., Ltd. and changed its name to INKON Life Technology Co., Ltd. in July 2019. INKON Life Technology Co., Ltd. was founded in 1998 and is headquartered in Qingdao, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 2,207
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300143

Financial Performance

In 2024, INKON Life Technology's revenue was 1.56 billion, an increase of 6.01% compared to the previous year's 1.47 billion. Earnings were 115.42 million, an increase of 14.92%.